Planta Med 2010; 76(11): 1044-1063
DOI: 10.1055/s-0030-1250111
Cancer Therapy
Reviews
© Georg Thieme Verlag KG Stuttgart · New York

Targeting Inflammatory Pathways by Flavonoids for Prevention and Treatment of Cancer

Sahdeo Prasad1 , Kannokarn Phromnoi1 , Vivek R. Yadav1 , Madan M. Chaturvedi1 , Bharat B. Aggarwal1
  • 1Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA
Further Information

Publication History

received February 23, 2010 revised June 8, 2010

accepted June 10, 2010

Publication Date:
15 July 2010 (online)

Abstract

Observational studies have suggested that lifestyle risk factors such as tobacco, alcohol, high-fat diet, radiation, and infections can cause cancer and that a diet consisting of fruits and vegetables can prevent cancer. Evidence from our laboratory and others suggests that agents either causing or preventing cancer are linked through the regulation of inflammatory pathways. Genes regulated by the transcription factor NF-κB have been shown to mediate inflammation, cellular transformation, tumor cell survival, proliferation, invasion, angiogenesis, and metastasis. Whereas various lifestyle risk factors have been found to activate NF-κB and NF-κB-regulated gene products, flavonoids derived from fruits and vegetables have been found to suppress this pathway. The present review describes various flavones, flavanones, flavonols, isoflavones, anthocyanins, and chalcones derived from fruits, vegetables, legumes, spices, and nuts that can suppress the proinflammatory cell signaling pathways and thus can prevent and even treat the cancer.

References

  • 1 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M J. Cancer statistics, 2009.  CA Cancer J Clin. 2009;  59 225-249
  • 2 Bray F, Moller B. Predicting the future burden of cancer.  Nat Rev Cancer. 2006;  6 63-74
  • 3 Aggarwal B B, Vijayalekshmi R V, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.  Clin Cancer Res. 2009;  15 425-430
  • 4 Ho R. AANCART comes to Hawaii.  Hawaii Med J. 2004;  63 189-190 193
  • 5 Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism.  Cell. 1986;  47 921-928
  • 6 Karin M. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.  J Biol Chem. 1999;  274 27339-27342
  • 7 Pahl H L. Activators and target genes of Rel/NF-kappaB transcription factors.  Oncogene. 1999;  18 6853-6866
  • 8 Garg A, Aggarwal B B. Nuclear transcription factor-kappaB as a target for cancer drug development.  Leukemia. 2002;  16 1053-1068
  • 9 Kumar S, Sharma A, Madan B, Singhal V, Ghosh B. Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells.  Biochem Pharmacol. 2007;  73 1602-1612
  • 10 Orlowski R Z, Baldwin Jr A S. NF-kappaB as a therapeutic target in cancer.  Trends Mol Med. 2002;  8 385-389
  • 11 Valen G, Yan Z Q, Hansson G K. Nuclear factor kappa-B and the heart.  J Am Coll Cardiol. 2001;  38 307-314
  • 12 Jones W K, Brown M, Ren X, He S, McGuinness M. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?.  Cardiovasc Toxicol. 2003;  3 229-254
  • 13 Shoelson S E, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.  Int J Obes Relat Metab Disord. 2003;  27 (Suppl. 3) S49-S52
  • 14 Yang L, Cohn L, Zhang D H, Homer R, Ray A, Ray P. Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation.  J Exp Med. 1998;  188 1739-1750
  • 15 Das J, Chen C H, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation.  Nat Immunol. 2001;  2 45-50
  • 16 Gagliardo R, Chanez P, Mathieu M, Bruno A, Costanzo G, Gougat C, Vachier I, Bousquet J, Bonsignore G, Vignola A M. Persistent activation of nuclear factor-kappaB signaling pathway in severe uncontrolled asthma.  Am J Respir Crit Care Med. 2003;  168 1190-1198
  • 17 Roshak A K, Callahan J F, Blake S M. Small-molecule inhibitors of NF-kappaB for the treatment of inflammatory joint disease.  Curr Opin Pharmacol. 2002;  2 316-321
  • 18 Lecleire S, Hassan A, Marion-Letellier R, Antonietti M, Savoye G, Bôle-Feysot C, Lerebours E, Ducrotté P, Déchelotte P, Coëffier M. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in association with changes in nuclear factor-kappaB and p 38 mitogen-activated protein kinase pathways.  J Nutr. 2008;  138 2481-2486
  • 19 Huang C J, Nazarian R, Lee J, Zhao P M, Espinosa-Jeffrey A, de Vellis J. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor kappa B in a human oligodendroglioma cell line.  Int J Dev Neurosci. 2002;  20 289-296
  • 20 Mattson M P, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders.  J Clin Invest. 2001;  107 247-254
  • 21 Kaltschmidt B, Uherek M, Volk B, Baeuerle P A, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.  Proc Natl Acad Sci USA. 1997;  94 2642-2647
  • 22 Burke J R. Targeting I kappa B kinase for the treatment of inflammatory and other disorders.  Curr Opin Drug Discov Devel. 2003;  6 720-728
  • 23 Yamamoto Y, Gaynor R B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.  J Clin Invest. 2001;  107 135-142
  • 24 Gorman P N, Yao P, Seshadri V. Finding the answers in primary care: information seeking by rural and nonrural clinicians.  Stud Health Technol Inform. 2004;  107 1133-1137
  • 25 Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?.  Lancet. 2001;  357 539-545
  • 26 Coussens L M, Werb Z. Inflammation and cancer.  Nature. 2002;  420 860-867
  • 27 Kuper H, Adami H O, Trichopoulos D. Infections as a major preventable cause of human cancer.  J Intern Med. 2000;  248 171-183
  • 28 Hussain S P, Hofseth L J, Harris C C. Radical causes of cancer.  Nat Rev. 2003;  3 276-285
  • 29 de Visser K E, Eichten A, Coussens L M. Paradoxical roles of the immune system during cancer development.  Nat Rev Cancer. 2006;  6 24-37
  • 30 Castellarin S D, Di Gaspero G. Transcriptional control of anthocyanin biosynthetic genes in extreme phenotypes for berry pigmentation of naturally occurring grapevines.  BMC Plant Biol. 2007;  7 46
  • 31 Robak J, Gryglewski R J. Bioactivity of flavonoids.  Pol J Pharmacol. 1996;  48 555-564
  • 32 Havsteen B. Flavonoids, a class of natural products of high pharmacological potency.  Biochem Pharmacol. 1983;  32 1141-1148
  • 33 Hrazdina G, Zobel A M, Hoch H C. Biochemical, immunological, and immunocytochemical evidence for the association of chalcone synthase with endoplasmic reticulum membranes.  Proc Natl Acad Sci USA. 1987;  84 8966-8970
  • 34 Ververidis F, Trantas E, Douglas C, Vollmer G, Kretzschmar G, Panopoulos N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part II: reconstruction of multienzyme pathways in plants and microbes.  Biotechnol J. 2007;  2 1235-1249
  • 35 Wilmouth R C, Turnbull J J, Welford R W, Clifton I J, Prescott A G, Schofield C J. Structure and mechanism of anthocyanidin synthase from Arabidopsis thaliana.  Structure. 2002;  10 93-103
  • 36 Turnbull W B, Pease A R, Stoddart J F. Toward the synthesis of large oligosaccharide-based dendrimers.  Chembiochem. 2000;  1 70-74
  • 37 Saito K, Kobayashi M, Gong Z, Tanaka Y, Yamazaki M. Direct evidence for anthocyanidin synthase as a 2-oxoglutarate-dependent oxygenase: molecular cloning and functional expression of cDNA from a red forma of Perilla frutescens.  Plant J. 1999;  17 181-189
  • 38 Kitamura S, Shikazono N, Tanaka A. TRANSPARENT TESTA 19 is involved in the accumulation of both anthocyanins and proanthocyanidins in Arabidopsis.  Plant J. 2004;  37 104-114
  • 39 Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability.  Am J Clin Nutr. 2004;  79 727-747
  • 40 Hollman P C, van Trijp J M, Buysman M N, van der Gaag M S, Mengelers M J, de Vries J H, Katan M B. Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man.  FEBS Lett. 1997;  418 152-156
  • 41 Guy L, Vedrine N, Urpi-Sarda M, Gil-Izquierdo A, Al-Maharik N, Boiteux J P, Scalbert A, Rémésy C, Botting N C, Manach C. Orally administered isoflavones are present as glucuronides in the human prostate.  Nutr Cancer. 2008;  60 461-468
  • 42 Dalais F S, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter D A, Thomson W K, Wahlqvist M L. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.  Urology. 2004;  64 510-515
  • 43 Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.  Cancer Res. 2006;  66 1234-1240
  • 44 Flaig T W, Gustafson D L, Su L J, Zirrolli J A, Crighton F, Harrison G S, Pierson A S, Agarwal R, Glodé L M. A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.  Invest New Drugs. 2007;  25 139-146
  • 45 Flaig T W, Glode M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su L J, Li Y, Harrison G, Agarwal R, Crawford E D, Lucia M S, Pollak M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.  The Prostate. 2010;  70 848-855
  • 46 Felgines C, Texier O, Morand C, Manach C, Scalbert A, Régerat F, Rémésy C. Bioavailability of the flavanone naringenin and its glycosides in rats.  Am J Physiol Gastrointest Liver Physiol. 2000;  279 G1148-G1154
  • 47 Son T G, Camandola S, Mattson M P. Hormetic dietary phytochemicals.  Neuromol Med. 2008;  10 236-246
  • 48 Utesch D, Feige K, Dasenbrock J, Broschard T H, Harwood M, Danielewska-Nikiel B, Lines T C. Evaluation of the potential in vivo genotoxicity of quercetin.  Mutat Res. 2008;  654 38-44
  • 49 Shen K H, Chang J K, Hsu Y L, Kuo P L. Chalcone arrests cell cycle progression and induces apoptosis through induction of mitochondrial pathway and inhibition of nuclear factor kappa B signalling in human bladder cancer cells.  Basic Clin Pharmacol Toxicol. 2007;  101 254-261
  • 50 Liu Y C, Hsieh C W, Wu C C, Wung B S. Chalcone inhibits the activation of NF-kappaB and STAT3 in endothelial cells via endogenous electrophile.  Life Sci. 2007;  80 1420-1430
  • 51 Abuarqoub H, Foresti R, Green C J, Motterlini R. Heme oxygenase-1 mediates the anti-inflammatory actions of 2′-hydroxychalcone in RAW 264.7 murine macrophages.  Am J Physiol Cell Physiol. 2006;  290 C1092-C1099
  • 52 Lee S H, Seo G S, Kim J Y, Jin X Y, Kim H D, Sohn D H. Heme oxygenase 1 mediates anti-inflammatory effects of 2′,4′,6′-tris(methoxymethoxy) chalcone.  Eur J Pharmacol. 2006;  532 178-186
  • 53 Ban H S, Suzuki K, Lim S S, Jung S H, Lee S, Ji J, Lee H S, Lee Y S, Shin K H, Ohuchi K. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by 2′-hydroxychalcone derivatives in RAW 264.7 cells.  Biochem Pharmacol. 2004;  67 1549-1557
  • 54 Kim J B, Han A R, Park E Y, Kim J Y, Cho W, Lee J, Seo E K, Lee K T. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF-kappaB inactivation in RAW 264.7 macrophage cells.  Biol Pharm Bull. 2007;  30 2345-2351
  • 55 Sung B, Pandey M K, Aggarwal B B. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.  Mol Pharmacol. 2007;  71 1703-1714
  • 56 Kunnumakkara A B, Nair A S, Ahn K S, Pandey M K, Yi Z, Liu M, Aggarwal B B. Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis.  Blood. 2007;  109 5112-5121
  • 57 Ju W, Wang X, Shi H, Chen W, Belinsky S A, Lin Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells.  Mol Pharmacol. 2007;  71 1381-1388
  • 58 Pan M H, Lai C S, Wang Y J, Ho C T. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice.  Biochem Pharmacol. 2006;  72 1293-1303
  • 59 Shukla S, Gupta S. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.  Clin Cancer Res. 2004;  10 3169-3178
  • 60 Romier B, Van De Walle J, During A, Larondelle Y, Schneider Y J. Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells.  Brit J Nutr. 2008;  100 542-551
  • 61 Cheng P Y, Lee Y M, Wu Y S, Chang T W, Jin J S, Yen M H. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro.  Biochem Pharmacol. 2007;  73 793-804
  • 62 Nakamura N, Hayasaka S, Zhang X Y, Nagaki Y, Matsumoto M, Hayasaka Y, Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappaB binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line.  Exp Eye Res. 2003;  77 195-202
  • 63 Burnett B P, Jia Q, Zhao Y, Levy R M. A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation.  J Med Food. 2007;  10 442-451
  • 64 Li B Q, Fu T, Gong W H, Dunlop N, Kung H, Yan Y, Kang J, Wang J M. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines.  Immunopharmacology. 2000;  49 295-306
  • 65 Aquila S, Giner R M, Recio M C, Spegazzini E D, Rios J L. Anti-inflammatory activity of flavonoids from Cayaponia tayuya roots.  J Ethnopharmacol. 2009;  121 333-337
  • 66 Huang S T, Chen C T, Chieng K T, Huang S H, Chiang B H, Wang L F, Kuo H S, Lin C M. Inhibitory effects of a rice hull constituent on tumor necrosis factor alpha, prostaglandin E2, and cyclooxygenase-2 production in lipopolysaccharide-activated mouse macrophages.  Ann NY Acad Sci. 2005;  1042 387-395
  • 67 Takada Y, Aggarwal B B. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p 65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9.  J Biol Chem. 2004;  279 4750-4759
  • 68 Messmann R A, Ullmann C D, Lahusen T, Kalehua A, Wasfy J, Melillo G, Ding I, Headlee D, Figg W D, Sausville E A, Senderowicz A M. Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.  Clin Cancer Res. 2003;  9 562-570
  • 69 Kim H P, Park H, Son K H, Chang H W, Kang S S. Biochemical pharmacology of biflavonoids: implications for anti-inflammatory action.  Arch Pharm Res. 2008;  31 265-273
  • 70 Suh S J, Jin U H, Kim S H, Chang H W, Son J K, Lee S H, Son K H, Kim C H. Ochnaflavone inhibits TNF-alpha-induced human VSMC proliferation via regulation of cell cycle, ERK1/2, and MMP-9.  J Cell Biochem. 2006;  99 1298-1307
  • 71 Lee K W, Kang N J, Heo Y S, Rogozin E A, Pugliese A, Hwang M K, Bowden G T, Bode A M, Lee H J, Dong Z. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.  Cancer Res. 2008;  68 946-955
  • 72 Lee K W, Kang N J, Rogozin E A, Kim H G, Cho Y Y, Bode A M, Lee H J, Surh Y J, Bowden G T, Dong Z. Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1.  Carcinogenesis. 2007;  28 1918-1927
  • 73 Muñoz-Espada A C, Watkins B A. Cyanidin attenuates PGE2 production and cyclooxygenase-2 expression in LNCaP human prostate cancer cells.  J Nutr Biochem. 2006;  17 589-596
  • 74 Xu W, Liu J, Li C, Wu H Z, Liu Y W. Kaempferol-7-O-beta-D-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p 53-independent manner.  Cancer Lett. 2008;  264 229-240
  • 75 Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages.  Mediators Inflamm. 2007;  2007 45673
  • 76 Kim J Y, Jung K J, Choi J S, Chung H Y. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin.  Aging Cell. 2006;  5 401-411
  • 77 Singh R P, Mallikarjuna G U, Sharma G, Dhanalakshmi S, Tyagi A K, Chan D C, Agarwal C, Agarwal R. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.  Clin Cancer Res. 2004;  10 8641-8647
  • 78 Bito T, Roy S, Sen C K, Shirakawa T, Gotoh A, Ueda M, Ichihashi M, Packer L. Flavonoids differentially regulate IFN gamma-induced ICAM-1 expression in human keratinocytes: molecular mechanisms of action.  FEBS Lett. 2002;  520 145-152
  • 79 Ferrandiz M L, Gil B, Sanz M J, Ubeda A, Erazo S, González E, Negrete R, Pacheco S, Payá M, Alcaraz M J. Effect of bakuchiol on leukocyte functions and some inflammatory responses in mice.  J Pharm Pharmacol. 1996;  48 975-980
  • 80 Rajakangas J, Misikangas M, Paivarinta E, Mutanen M. Chemoprevention by white currant is mediated by the reduction of nuclear beta-catenin and NF-kappaB levels in Min mice adenomas.  Eur J Nutr. 2008;  47 115-122
  • 81 Boivin D, Blanchette M, Barrette S, Moghrabi A, Beliveau R. Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.  Anticancer Res. 2007;  27 937-948
  • 82 Chen P N, Kuo W H, Chiang C L, Chiou H L, Hsieh Y S, Chu S C. Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression.  Chem Biol Interact. 2006;  163 218-229
  • 83 Chen P N, Chu S C, Chiou H L, Kuo W H, Chiang C L, Hsieh Y S. Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line.  Cancer Lett. 2006;  235 248-259
  • 84 Afaq F, Malik A, Syed D, Maes D, Matsui M S, Mukhtar H. Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign.  Photochem Photobiol. 2005;  81 38-45
  • 85 Kang J L, Lee H W, Lee H S, Pack I S, Chong Y, Castranova V, Koh Y. Genistein prevents nuclear factor-kappa B activation and acute lung injury induced by lipopolysaccharide.  Am J Respir Crit Care Med. 2001;  164 2206-2212
  • 86 Kang J S, Yoon Y D, Han M H, Han S B, Lee K, Kang M R, Moon E Y, Jeon Y J, Park S K, Kim H M. Estrogen receptor-independent inhibition of tumor necrosis factor-alpha gene expression by phytoestrogen equol is mediated by blocking nuclear factor-kappaB activation in mouse macrophages.  Biochem Pharmacol. 2005;  71 136-143
  • 87 Manna S K, Aggarwal R S, Sethi G, Aggarwal B B, Ramesh G T. Morin (3,5, 7,2′,4′-pentahydroxyflavone) abolishes nuclear factor-kappaB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear factor-kappaB-regulated gene expression and up-regulation of apoptosis.  Clin Cancer Res. 2007;  13 2290-2297
  • 88 Tabary O, Escotte S, Couetil J P, Hubert D, Dusser D, Puchelle E, Jacquot J. Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells.  Pflugers Arch. 2001;  443 (Suppl. 1) S40-S44
  • 89 Kang J S, Yoon Y D, Cho I J, Han M H, Lee C W, Park S K, Kim H M. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.  J Pharmacol Exp Ther. 2005;  312 1187-1194
  • 90 Ahn K S, Noh E J, Cha K H, Kim Y S, Lim S S, Shin K H, Jung S H. Inhibitory effects of irigenin from the rhizomes of Belamcanda chinensis on nitric oxide and prostaglandin E(2) production in murine macrophage RAW 264.7 cells.  Life Sci. 2006;  78 2336-2342
  • 91 De Melo G O, Muzitano M F, Legora-Machado A, Almeida T A, De Oliveira D B, Kaiser C R, Koatz V L, Costa S S. C-glycosylflavones from the aerial parts of Eleusine indica inhibit LPS-induced mouse lung inflammation.  Planta Med. 2005;  71 362-363
  • 92 Chen K H, Weng M S, Lin J K. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p 38 MAPK, JNK, and AKT activation in human lung carcinoma cells.  Biochem Pharmacol. 2007;  73 215-227
  • 93 Tuchinda P, Saiai A, Pohmakotr M, Yoosook C, Kasisit J, Napaswat C, Santisuk T, Reutrakul V. Anti-HIV-1 cycloartanes from leaves and twigs of Gardenia thailandica.  Planta Med. 2004;  70 366-370
  • 94 Lowe S W, Lin A W. Apoptosis in cancer.  Carcinogenesis. 2000;  21 485-495
  • 95 Shishodia S, Aggarwal B B. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.  Cancer Treat Res. 2004;  119 139-173
  • 96 Dorn C, Kraus B, Motyl M, Weiss T S, Gehrig M, Schölmerich J, Heilmann J, Hellerbrand C. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.  Mol Nutr Food Res. ;  , in press
  • 97 Harikumar K B, Kunnumakkara A B, Ahn K S, Anand P, Krishnan S, Guha S, Aggarwal B B. Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p 65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.  Blood. 2009;  113 2003-2013
  • 98 Pandey M K, Sung B, Ahn K S, Aggarwal B B. Butein suppresses constitutive and inducible signal transducer and activator of transcription (STAT) 3 activation and STAT3-regulated gene products through the induction of a protein tyrosine phosphatase SHP-1.  Mol Pharmacol. 2009;  75 525-533
  • 99 Wang Y, Chan F L, Chen S, Leung L K. The plant polyphenol butein inhibits testosterone-induced proliferation in breast cancer cells expressing aromatase.  Life Sci. 2005;  77 39-51
  • 100 Hsu Y L, Kuo P L, Chiang L C, Lin C C. Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells.  Clin Exp Pharmacol Physiol. 2004;  31 414-418
  • 101 Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Isoliquiritigenin inhibits the growth of prostate cancer.  Eur Urol. 2003;  43 580-586
  • 102 Ma J, Fu N Y, Pang D B, Wu W Y, Xu A L. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells.  Planta Med. 2001;  67 754-757
  • 103 Yamazaki S, Morita T, Endo H, Hamamoto T, Baba M, Joichi Y, Kaneko S, Okada Y, Okuyama T, Nishino H, Tokue A. Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma.  Cancer Lett. 2002;  183 23-30
  • 104 Kimura Y, Taniguchi M, Baba K. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.  Planta Med. 2004;  70 211-219
  • 105 Kimura Y, Baba K. Antitumor and antimetastatic activities of Angelica keiskei roots, part 1: isolation of an active substance, xanthoangelol.  Int J Cancer. 2003;  106 429-437
  • 106 Lee Y S, Lim S S, Shin K H, Kim Y S, Ohuchi K, Jung S H. Anti-angiogenic and anti-tumor activities of 2′-hydroxy-4′-methoxychalcone.  Biol Pharm Bull. 2006;  29 1028-1031
  • 107 Li Z D, Hu X W, Wang Y T, Fang J. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1.  FEBS Lett. 2009;  583 1999-2003
  • 108 Franzen C A, Amargo E, Todorovic V, Desai B V, Huda S, Mirzoeva S, Chiu K, Grzybowski B A, Chew T L, Green K J, Pelling J C. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.  Cancer Prev Res (Phila Pa). 2009;  2 830-841
  • 109 Hu X W, Meng D, Fang J. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.  Carcinogenesis. 2008;  29 2369-2376
  • 110 Lee W J, Chen W K, Wang C J, Lin W L, Tseng T H. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.  Toxicol Appl Pharmacol. 2008;  226 178-191
  • 111 Androutsopoulos V P, Mahale S, Arroo R R, Potter G. Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.  Oncol Rep. 2009;  21 1525-1528
  • 112 Lin Y, Shi R, Wang X, Shen H M. Luteolin, a flavonoid with potential for cancer prevention and therapy.  Curr Cancer Drug Targets. 2008;  8 634-646
  • 113 Wu B, Zhang Q, Shen W, Zhu J. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line.  Mol Cell Biochem. 2008;  313 125-132
  • 114 Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, Fotsis T. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity.  Cancer Res. 2004;  64 7936-7946
  • 115 Zhou Q, Yan B, Hu X, Li X B, Zhang J, Fang J. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.  Mol Cancer Ther. 2009;  8 1684-1691
  • 116 Chang H L, Su J H, Yeh Y T, Lee Y C, Chen H M, Wu Y C, Yuan S S. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo.  Cancer Lett. 2008;  267 85-95
  • 117 Luo G, Guan X, Zhou L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo.  Cancer Biol Ther. 2008;  7 966-973
  • 118 Miyata Y, Sato T, Yano M, Ito A. Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.  Mol Cancer Ther. 2004;  3 839-847
  • 119 Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells.  Biochem Biophys Res Commun. 2008;  366 168-173
  • 120 Morley K L, Ferguson P J, Koropatnick J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.  Cancer Lett. 2007;  251 168-178
  • 121 Bracke M E, Vyncke B M, Van Larebeke N A, Bruyneel E A, De Bruyne G K, De Pestel G H, De Coster W J, Espeel M F, Mareel M M. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro.  Clin Exp Metastasis. 1989;  7 283-300
  • 122 Murillo G, Hirschelman W H, Ito A, Moriarty R M, Kinghorn A D, Pezzuto J M, Mehta R G. Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis.  Nutr Cancer. 2007;  57 28-37
  • 123 Pan M H, Lai C S, Hsu P C, Wang Y J. Acacetin induces apoptosis in human gastric carcinoma cells accompanied by activation of caspase cascades and production of reactive oxygen species.  J Agric Food Chem. 2005;  53 620-630
  • 124 Singh R P, Agrawal P, Yim D, Agarwal C, Agarwal R. Acacetin inhibits cell growth and cell cycle progression, and induces apoptosis in human prostate cancer cells: structure-activity relationship with linarin and linarin acetate.  Carcinogenesis. 2005;  26 845-854
  • 125 Yang S F, Yang W E, Kuo W H, Chang H R, Chu S C, Hsieh Y S. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases.  Arch Oral Biol. 2008;  53 287-294
  • 126 Zhu Q, Barakat B M, Wani G, Zhao Q, El-Mahdy M A, Wani A A Arafa el-SA. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.  Cancer Res. 2009;  69 8910-8917
  • 127 Peng C Y, Pan S L, Huang Y W, Guh J H, Chang Y L, Teng C M. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.  Naunyn Schmiedebergs Arch Pharmacol. 2008;  378 579-588
  • 128 Androutsopoulos V P, Ruparelia K, Arroo R R, Tsatsakis A M, Spandidos D A. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.  Toxicology. 2009;  264 162-170
  • 129 Du G, Han G, Zhang S, Lin H, Wu X, Wang M, Ji L, Lu L, Yu L, Liang W. Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1alpha inhibition.  Eur J Pharmacol. 2010;  630 121-130
  • 130 Li Y, Bhuiyan M, Alhasan S, Senderowicz A M, Sarkar F H. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.  Clin Cancer Res. 2000;  6 223-229
  • 131 Luo H, Rankin G O, Liu L, Daddysman M K, Jiang B H, Chen Y C. Kaempferol inhibits angiogenesis and VEGF expression through both HIF dependent and independent pathways in human ovarian cancer cells.  Nutr Cancer. 2009;  61 554-563
  • 132 Li W, Du B, Wang T, Wang S, Zhang J. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the ataxia-telangiectasia mutated-p 53 pathway with the involvement of p 53 upregulated modulator of apoptosis.  Chem Biol Interact. 2009;  177 121-127
  • 133 Chien S Y, Wu Y C, Chung J G, Yang J S, Lu H F, Tsou M F, Wood W, Kuo S J, Chen D R. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells.  Hum Exp Toxicol. 2009;  28 493-503
  • 134 Tan J, Wang B, Zhu L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin.  Chem Biodivers. 2009;  6 1101-1110
  • 135 Shan B E, Wang M X, Li R Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.  Cancer Invest. 2009;  27 604-612
  • 136 Zhang W, Zhang F. Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells.  Eur J Gynaecol Oncol. 2009;  30 60-64
  • 137 Siegelin M D, Reuss D E, Habel A, Rami A, von Deimling A. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.  Neuro Oncol. 2009;  11 122-131
  • 138 Kim E J, Choi C H, Park J Y, Kang S K, Kim Y K. Underlying mechanism of quercetin-induced cell death in human glioma cells.  Neurochem Res. 2008;  33 971-979
  • 139 van der Woude H, Ter Veld M G, Jacobs N, van der Saag P T, Murk A J, Rietjens I M. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor.  Mol Nutr Food Res. 2005;  49 763-771
  • 140 Amado N G, Cerqueira D M, Menezes F S, da Silva J F, Neto V M, Abreu J G. Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization.  Anticancer Drugs. 2009;  20 543-552
  • 141 Lin J P, Yang J S, Lu C C, Chiang J H, Wu C L, Lin J J, Lin H L, Yang M D, Liu K C, Chiu T H, Chung J G. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo.  Leuk Res. 2009;  33 823-828
  • 142 Ali H A, Chowdhury A K, Rahman A K, Borkowski T, Nahar L, Sarker S D. Pachypodol, a flavonol from the leaves of Calycopteris floribunda, inhibits the growth of CaCo-2 colon cancer cell line in vitro.  Phytother Res. 2008;  22 1684-1687
  • 143 van Ginkel P R, Sareen D, Subramanian L, Walker Q, Darjatmoko S R, Lindstrom M J, Kulkarni A, Albert D M, Polans A S. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria.  Clin Cancer Res. 2007;  13 5162-5169
  • 144 Cecchinato V, Chiaramonte R, Nizzardo M, Cristofaro B, Basile A, Sherbet G V, Comi P. Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells.  Biochem Pharmacol. 2007;  74 1568-1574
  • 145 Marel A K, Lizard G, Izard J C, Latruffe N, Delmas D. Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells.  Mol Nutr Food Res. 2008;  52 538-548
  • 146 Roccaro A M, Leleu X, Sacco A, Moreau A S, Hatjiharissi E, Jia X, Xu L, Ciccarelli B, Patterson C J, Ngo H T, Russo D, Vacca A, Dammacco F, Anderson K C, Ghobrial I M, Treon S P. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia.  Clin Cancer Res. 2008;  14 1849-1858
  • 147 Zhao W, Bao P, Qi H, You H. Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells.  Oncol Rep. 2010;  23 279-286
  • 148 Schlachterman A, Valle F, Wall K M, Azios N G, Castillo L, Morell L, Washington A V, Cubano L A, Dharmawardhane S F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model.  Transl Oncol. 2008;  1 19-27
  • 149 Castillo-Pichardo L, Martinez-Montemayor M M, Martinez J E, Wall K M, Cubano L A, Dharmawardhane S. Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols.  Clin Exp Metastasis. 2009;  26 505-516
  • 150 De Leo M, Braca A, Sanogo R, Cardile V, DeTommasi N, Russo A. Antiproliferative activity of Pteleopsis suberosa leaf extract and its flavonoid components in human prostate carcinoma cells.  Planta Med. 2006;  72 604-610
  • 151 Lin J, Zhang S M, Wu K, Willett W C, Fuchs C S, Giovannucci E. Flavonoid intake and colorectal cancer risk in men and women.  Am J Epidemiol. 2006;  164 644-651
  • 152 Ko C H, Shen S C, Lin H Y, Hou W C, Lee W R, Yang L L, Chen Y C. Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process.  J Cell Physiol. 2002;  193 93-102
  • 153 Hsiao Y C, Kuo W H, Chen P N, Chang H R, Lin T H, Yang W E, Hsieh Y S, Chu S C. Flavanone and 2′-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway.  Chem Biol Interact. 2007;  167 193-206
  • 154 Virgili F, Acconcia F, Ambra R, Rinna A, Totta P, Marino M. Nutritional flavonoids modulate estrogen receptor alpha signaling.  IUBMB Life. 2004;  56 145-151
  • 155 Bulzomi P, Bolli A, Galluzzo P, Leone S, Acconcia F, Marino M. Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth.  IUBMB Life. 2010;  62 51-60
  • 156 Totta P, Acconcia F, Leone S, Cardillo I, Marino M. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.  IUBMB Life. 2004;  56 491-499
  • 157 Deep G, Singh R P, Agarwal C, Kroll D J, Agarwal R. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.  Oncogene. 2006;  25 1053-1069
  • 158 Dorta D J, Pigoso A A, Mingatto F E, Rodrigues T, Prado I M, Helena A F, Uyemura S A, Santos A C, Curti C. The interaction of flavonoids with mitochondria: effects on energetic processes.  Chem Biol Interact. 2005;  152 67-78
  • 159 Choi E J, Lee J I, Kim G H. Anti-carcinogenic effect of a new analogue 4′-chloroflavanone from flavanone in human breast cancer cells.  Int J Mol Med. 2010;  25 293-298
  • 160 Rho Y H, Lee B W, Park K H, Bae Y S. Cudraflavanone A purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells, at least in part, through the inhibition of DNA topoisomerase I and protein kinase C activity.  Anticancer Drugs. 2007;  18 1023-1028
  • 161 He Q, Li R, Fang L, Ying H, Hu Y, Yang B. Antileukemia activity of MSFTZ-a novel flavanone analog.  Anticancer Drugs. 2006;  17 641-647
  • 162 Singletary K W, Stansbury M J, Giusti M, Van Breemen R B, Wallig M, Rimando A. Inhibition of rat mammary tumorigenesis by concord grape juice constituents.  J Agric Food Chem. 2003;  51 7280-7286
  • 163 Cai H, Marczylo T H, Teller N, Brown K, Steward W P, Marko D, Gescher A J. Anthocyanin-rich red grape extract impedes adenoma development in the Apc(Min) mouse: pharmacodynamic changes and anthocyanin levels in the murine biophase.  Eur J Cancer. 2010;  46 811-817
  • 164 Seeram N P, Adams L S, Hardy M L, Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines.  J Agric Food Chem. 2004;  52 2512-2517
  • 165 Olsson M E, Gustavsson K E, Andersson S, Nilsson A, Duan R D. Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels.  J Agric Food Chem. 2004;  52 7264-7271
  • 166 Afaq F, Syed D N, Malik A, Hadi N, Sarfaraz S, Kweon M H, Khan N, Zaid M A, Mukhtar H. Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVB-mediated oxidative stress and apoptosis.  J Invest Dermatol. 2007;  127 222-232
  • 167 Reddivari L, Vanamala J, Chintharlapalli S, Safe S H, Miller Jr J C. Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways.  Carcinogenesis. 2007;  28 2227-2235
  • 168 Martin S, Giannone G, Andriantsitohaina R, Martinez M C. Delphinidin, an active compound of red wine, inhibits endothelial cell apoptosis via nitric oxide pathway and regulation of calcium homeostasis.  Br J Pharmacol. 2003;  139 1095-1102
  • 169 Kuo P L, Hsu Y L, Lin T C, Lin C C. The antiproliferative activity of prodelphinidin B-2 3′-O-gallate from green tea leaf is through cell cycle arrest and Fas-mediated apoptotic pathway in A549 cells.  Food Chem Toxicol. 2005;  43 315-323
  • 170 Zhang Y, Vareed S K, Nair M G. Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables.  Life Sci. 2005;  76 1465-1472
  • 171 Shih P H, Yeh C T, Yen G C. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells.  Food Chem Toxicol. 2005;  43 1557-1566
  • 172 Wang L S, Hecht S S, Carmella S G, Yu N, Larue B, Henry C, McIntyre C, Rocha C, Lechner J F, Stoner G D. Anthocyanins in black raspberries prevent esophageal tumors in rats.  Cancer Prev Res (Phila Pa). 2009;  2 84-93
  • 173 Hafeez B B, Siddiqui I A, Asim M, Malik A, Afaq F, Adhami V M, Saleem M, Din M, Mukhtar H. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling.  Cancer Res. 2008;  68 8564-8572
  • 174 Favot L, Martin S, Keravis T, Andriantsitohaina R, Lugnier C. Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis.  Cardiovasc Res. 2003;  59 479-487
  • 175 Huang H P, Shih Y W, Chang Y C, Hung C N, Wang C J. Chemoinhibitory effect of mulberry anthocyanins on melanoma metastasis involved in the Ras/PI3K pathway.  J Agric Food Chem. 2008;  56 9286-9293
  • 176 Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R, Schweigerer L. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.  J Nutr. 1995;  125 790S-797S
  • 177 Barnes S. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer.  Breast Cancer Res Treat. 1997;  46 169-179
  • 178 Verma S P, Goldin B R. Effect of soy-derived isoflavonoids on the induced growth of MCF-7 cells by estrogenic environmental chemicals.  Nutr Cancer. 1998;  30 232-239
  • 179 Jung S H, Lee Y S, Lee S, Lim S S, Kim Y S, Ohuchi K, Shin K H. Anti-angiogenic and anti-tumor activities of isoflavonoids from the rhizomes of Belamcanda chinensis.  Planta Med. 2003;  69 617-622
  • 180 Maurich T, Iorio M, Chimenti D, Turchi G. Erybraedin C and bitucarpin A, two structurally related pterocarpans purified from Bituminaria bituminosa, induced apoptosis in human colon adenocarcinoma cell lines MMR- and p 53-proficient and -deficient in a dose-, time-, and structure-dependent fashion.  Chem Biol Interact. 2006;  159 104-116
  • 181 Choi H J, Eun J S, Kim B G, Kim S Y, Jeon H, Soh Y. Vitexin, an HIF-1alpha inhibitor, has anti-metastatic potential in PC12 cells.  Mol Cells. 2006;  22 291-299
  • 182 You K M, Son K H, Chang H W, Kang S S, Kim H P. Vitexicarpin, a flavonoid from the fruits of Vitex rotundifolia, inhibits mouse lymphocyte proliferation and growth of cell lines in vitro.  Planta Med. 1998;  64 546-550
  • 183 Clubbs E A, Bomser J A. Basal cell induced differentiation of noncancerous prostate epithelial cells (RWPE-1) by glycitein.  Nutr Cancer. 2009;  61 390-396
  • 184 Clubbs E A, Bomser J A. Glycitein activates extracellular signal-regulated kinase via vascular endothelial growth factor receptor signaling in nontumorigenic (RWPE-1) prostate epithelial cells.  J Nutr Biochem. 2007;  18 525-532
  • 185 Pan M H, Chen W J, Lin-Shiau S Y, Ho C T, Lin J K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p 21 and p 27 in human colorectal carcinoma cells.  Carcinogenesis. 2002;  23 1677-1684
  • 186 Lichius J J, Thoison O, Montagnac A, Païs M, Guéritte-Voegelein F, Sévenet T, Cosson J P, Hadi A H. Antimitotic and cytotoxic flavonols from Zieridium pseudobtusifolium and Acronychia porteri.  J Nat Products. 1994;  57 1012-1016
  • 187 Shi Q, Chen K, Li L, Chang J J, Autry C, Kozuka M, Konoshima T, Estes J R, Lin C M, Hamel E. Antitumor agents, 154. Cytotoxic and antimitotic flavonols from Polanisia dodecandra.  J Nat Products. 1995;  58 475-482
  • 188 Dorn C, Weiss T S, Heilmann J, Hellerbrand C. Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.  Int J Oncol. 2010;  36 435-441
  • 189 Guruvayoorappan C, Kuttan G. Amentoflavone stimulates apoptosis in B16F-10 melanoma cells by regulating bcl-2, p 53 as well as caspase-3 genes and regulates the nitric oxide as well as proinflammatory cytokine production in B16F-10 melanoma cells, tumor associated macrophages and peritoneal macrophages.  J Exp Ther Oncol. 2008;  7 207-218
  • 190 Aalinkeel R, Hu Z, Nair B B, Sykes D E, Reynolds J L, Mahajan S D, Schwartz S H. Genomic analysis highlights the role of the JAK-STAT signaling in the anti-proliferative effects of dietary flavonoid 'Ashwagandha' in prostate cancer cells.  Evid Based Complement Alternat Med. 2010;  7 177-187
  • 191 Guruvayoorappan C, Kuttan G. Rutin inhibits nitric oxide and tumor necrosis factor-alpha production in lipopolysaccharide and concanavalin-a stimulated macrophages.  Drug Metabol Drug Interact. 2007;  22 263-278
  • 192 Bandyopadhyay S, Romero J R, Chattopadhyay N. Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells.  Mol Cell Endocrinol. 2008;  287 57-64
  • 193 Lee S, Kim Y J, Kwon S, Lee Y, Choi S Y, Park J, Kwon H J. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells.  BMB Rep. 2009;  42 265-270
  • 194 Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra M K, Sen E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress.  Mol Cancer Ther. 2007;  6 2544-2553
  • 195 Liu S, Ma Z, Cai H, Li Q, Rong W, Kawano M. Inhibitory effect of baicalein on IL-6-mediated signaling cascades in human myeloma cells.  Eur J Haematol. 2009;  84 137-144
  • 196 Chittezhath M, Deep G, Singh R P, Agarwal C, Agarwal R. Silibinin inhibits cytokine-induced signaling cascades and down-regulates inducible nitric oxide synthase in human lung carcinoma A549 cells.  Mol Cancer Ther. 2008;  7 1817-1826
  • 197 Cortes J R, Perez G M, Rivas M D, Zamorano J. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3.  J Immunol. 2007;  179 3881-3887
  • 198 Shchemelinin I, Sefc L, Necas E. Protein kinases, their function and implication in cancer and other diseases.  Folia Biol (Praha). 2006;  52 81-100
  • 199 Fabbro D, Ruetz S, Buchdunger E, Cowan-Jacob S W, Fendrich G, Liebetanz J, Mestan J, O'Reilly T, Traxler P, Chaudhuri B, Fretz H, Zimmermann J, Meyer T, Caravatti G, Furet P, Manley P W. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.  Pharmacol Ther. 2002;  93 79-98
  • 200 Teillet F, Boumendjel A, Boutonnat J, Ronot X. Flavonoids as RTK inhibitors and potential anticancer agents.  Med Res Rev. 2008;  28 715-745
  • 201 Zhang J, Yang P L, Gray N S. Targeting cancer with small molecule kinase inhibitors.  Nat Rev Cancer. 2009;  9 28-39
  • 202 Schroeter H, Boyd C, Spencer J P, Williams R J, Cadenas E, Rice-Evans C. MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide.  Neurobiol Aging. 2002;  23 861-880
  • 203 Virgili F, Marino M. Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity.  Free Radic Biol Med. 2008;  45 1205-1216
  • 204 Williams R J, Spencer J P, Rice-Evans C. Flavonoids: antioxidants or signalling molecules?.  Free Radic Biol Med. 2004;  36 838-849
  • 205 Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition.  Biochem Pharmacol. 1997;  53 1649-1657
  • 206 Matter W F, Brown R F, Vlahos C J. The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs.  Biochem Biophys Res Commun. 1992;  186 624-631
  • 207 Spencer J P, Rice-Evans C, Williams R J. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability.  J Biol Chem. 2003;  278 34783-34793
  • 208 Gamet-Payrastre L, Manenti S, Gratacap M P, Tulliez J, Chap H, Payrastre B. Flavonoids and the inhibition of PKC and PI 3-kinase.  Gen Pharmacol. 1999;  32 279-286
  • 209 Kong A N, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis.  Arch Pharm Res. 2000;  23 1-16
  • 210 Kumamoto T, Fujii M, Hou D X. Myricetin directly targets JAK1 to inhibit cell transformation.  Cancer Lett. 2009;  275 17-26
  • 211 Jung S K, Lee K W, Byun S, Kang N J, Lim S H, Heo Y S, Bode A M, Bowden G T, Lee H J, Dong Z. Myricetin suppresses UVB-induced skin cancer by targeting Fyn.  Cancer Res. 2008;  68 6021-6029
  • 212 Kim J E, Kwon J Y, Lee D E, Kang N J, Heo Y S, Lee K W, Lee H J. MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin.  Biochem Pharmacol. 2009;  77 412-421
  • 213 He Z, Tang F, Ermakova S, Li M, Zhao Q, Cho Y Y, Ma W Y, Choi H S, Bode A M, Yang C S, Dong Z. Fyn is a novel target of (−)-epigallocatechin gallate in the inhibition of JB6 Cl41 cell transformation.  Mol Carcinogen. 2008;  47 172-183
  • 214 Walker E H, Pacold M E, Perisic O, Stephens L, Hawkins P T, Wymann M P, Williams R L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.  Mol Cell. 2000;  6 909-919
  • 215 Kang N J, Lee K W, Rogozin E A, Cho Y Y, Heo Y S, Bode A M, Lee H J, Dong Z. Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p 90RSK/activator protein-1 pathway.  J Biol Chem. 2007;  282 32856-32866

Bharat B. Aggarwal

M. D. Anderson Cancer Center
The University of Texas

1515 Holcombe Blvd.

Box 143

Houston, TX 77030

USA

Phone: + 17 1 37 94 18 17

Fax: + 17 1 37 45 63 39

Email: aggarwal@mdanderson.org

    >